Anhui Fengyuan Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,743.408 million compared to CNY 1,577.762 million a year ago. Operating income was CNY 88.356 million compared to CNY 76.243 million a year ago. Net income was CNY 63.582 million compared to CNY 57.751 million a year ago. Basic earnings per share from continuing operations was CNY 0.2037 compared to CNY 0.185 a year ago.